Previous Page  10 / 20 Next Page
Information
Show Menu
Previous Page 10 / 20 Next Page
Page Background

Page 43

conferenceseries

.com

Volume 7, Issue 4 (Suppl)

J Clin Trial

ISSN: 2167-0870 JCTR, an open access journal

Global Pharmacovigilance 2017

July 06-07, 2017

JULY 06-07, 2017 KUALA LUMPUR, MALAYSIA

8

TH

GLOBAL

Pharmacovigilance &

Drug Safety Summit

J Clin Trial 2017, 7:4 (Suppl)

DOI: 10.4172/2167-0870-C1-017

Multifaceted role of gamma-Tocotrienol in cancer therapy

Gautam Sethi

National University of Singapore, Singapore

G

amma-Tocotrienol, a member of Vitamin E super-family has attracted great attention of late for its anti-proliferative and

anti-carcinogenic potential against different cancers. For example, our group has recently reported that anti-proliferative

and chemo-sensitizing effects of Gamma-tocotrienol are associated with its ability to suppress activation of signal transducers

and activator of transcription 3 (STAT3), a pro-inflammatory transcription factor that plays a pivotal role in the survival,

proliferation, angiogenesis and chemo-resistance of hepatocellular carcinoma. However, the potential of gamma-tocotrienol

to overcome chemo-resistance in gastric cancer, which is one of the deadliest cancers in Asia-pacific region, has never been

explored before. Hence, we investigated the efficacy of Gamma-tocotrienol in combination with capecitabine to modulate

tumor growth and survival in xenograft mouse model. Gamma-tocotrienol also inhibited expression of various oncogenic

proteins, induced PARP cleavage and inhibited NF-κB activation in gastric cancer cells.

In vivo

studies using xenograft model

of human gastric cancer demonstrated that gamma-tocotrienol alone suppressed tumor growth and this effect was further

potentiated in conjunction with capecitabine. As compared to the vehicle control, gamma-tocotrienol further suppressed the

NF-κB activation and expression of cyclin D1, COX-2, ICAM-1, MMP-9 and survivin in tumor tissues obtained from treatment

groups. Additionally we noted, that gamma tocotrienol can function as a potent inhibitor of angigogenesis in both HUVEC

and HCC cells. Overall our results suggest for the first time that gamma-tocotrienol can potentiate the effects of chemotherapy

through modulation of multiple biomarkers of proliferation and angiogenesis in diverse cancers.

gautam_sethi@nuhs.edu.sg